University of Pavia-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2019

  1. Update of the statements on biology and clinical impact of occult hepatitis B virus infection

    Journal of Hepatology, Vol. 71, Núm. 2, pp. 397-408

2015

  1. Differences in the availability of diagnostics and treatment modalities for chronic hepatitis B across Europe

    Clinical Microbiology and Infection, Vol. 21, Núm. 11, pp. 1027-1032

2008

  1. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults

    HIV Medicine, Vol. 9, Núm. 2, pp. 82-88

  2. Response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C due to genotype 4

    Journal of Viral Hepatitis, Vol. 15, Núm. 10, pp. 710-715

2006

  1. Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection

    AIDS, Vol. 20, Núm. 15, pp. 1951-1954

2004

  1. Comments on the review 'Care of patients with hepatitis C and HIV co-infection' by Soriano et al. [2] (multiple letters)

    AIDS

  2. Hepatocellular carcinoma in HIV-infected patients: Epidemiological features, clinical presentation and outcome

    AIDS, Vol. 18, Núm. 17, pp. 2285-2293

2002

  1. HCV chronic hepatitis in patients with HIV: Clinical management issues

    American Journal of Gastroenterology, Vol. 97, Núm. 7, pp. 1598-1606